Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Personal Genomics, Inc. (PGI) is a Taiwan-based biotechnology company specializing in the development of advanced next-generation sequencing (NGS) technologies. The company focuses on a proprietary optoelectronic sequencing platform that enables single-molecule, real-time (SMRT) detection without the need for PCR amplification. Their technology aims to provide high-accuracy, long-read sequencing for applications in clinical diagnostics, personalized medicine, and agricultural biotechnology. PGI's solutions include both hardware platforms and comprehensive genomic analysis services designed to lower the cost and complexity of genetic testing. By integrating semiconductor technology with molecular biology, the company seeks to revolutionize the accessibility of genomic information.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Personal Genomics of Taiwan.